查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
單細胞分析市場規模、份額和趨勢分析：按產品、技術、應用、最終用戶、地區、競爭戰略、細分市場預測至2030
市場調查報告書
商品編碼
1100080

單細胞分析市場規模、份額和趨勢分析：按產品、技術、應用、最終用戶、地區、競爭戰略、細分市場預測至2030

Single Cell Analysis Market Size, Share & Trends Analysis By Product, By Technique, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 245 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

到 2030 年，全球單細胞分析市場規模預計將達到 105.7 億美元，複合年增長率為 14.6%。癌症患病率的上升正在推動這個市場的增長。

本報告研究了全球單細胞分析市場，並提供了市場概況、市場動態、市場前景、細分和區域分析、主要參與者的概況等。

第一章介紹

第二章研究方法

第 3 章執行摘要

第 4 章市場概述

  • 簡介
  • 市場動態
    • 驅動程序
    • 約束因素
    • 市場機會
    • 任務
  • COVID-19 對單細胞分析市場的影響
  • 市場趨勢

第 5 章全球單細胞分析市場：按產品分類（2019-2030）

  • 消耗品
    • 珠子
    • 微孔板
    • 試劑
    • 檢測試劑盒
    • 其他（培養皿、燒瓶、試管、比色皿、冷凍管、過濾裝置、培養皿、插入物、圓盤）
  • 設備
    • 流式細胞儀
    • NGS 系統
    • PCR 設備
    • 分光光度計
    • 顯微鏡
    • 細胞計數器
    • HCS 系統
    • 微陣列
    • 其他
    • 單細胞分析：按細胞類型
    • 人體細胞
    • 動物細胞
    • 微生物細胞

第 6 章全球單細胞分析市場：按技術（2019-2030 年）

  • 流式細胞術
  • 二代測序
  • 聚合□鍊式反應
  • 顯微鏡
  • 質譜
  • 其他

第 7 章全球單細胞分析市場：按應用（2019-2030 年）

  • 研究用途
    • 癌症
    • 免疫學
    • 神經科
    • 幹細胞
    • 其他
  • 醫療應用
    • 無創產前診斷
    • 體外受精
    • 檢測循環腫瘤細胞

第 8 章全球單細胞分析市場：按最終用戶分類（2019-2030 年）

  • 學術研究實驗室
  • 生物技術和製藥公司
  • 醫院和診斷實驗室
  • 細胞庫/體外受精中心

第 9 章全球單細胞分析市場：按地區劃分（2019-2030 年）

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區
    • 拉丁美洲
    • 中東和非洲

第 10 章競爭格局

  • 簡介
  • 市場份額分析：按主要公司
  • 競爭場景
    • 產品發布
    • 夥伴關係、合作和合同
    • 收購
    • 擴展名
    • 其他發展

第 11 章公司簡介

  • 10x Genomics
  • Agilent Technologies, Inc.
  • Apogee Flow Systems Ltd.
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories
  • Corning Incorporated
  • Cytek Biosciences
  • Danaher Corporation
  • Fluidigm Corporation
  • Fluxion Biosciences
  • Illumina, Inc.
  • Luminex Corporation
  • Menarini Silicon Biosystems, Inc.
  • Merck KGAA
  • NanoCellect Biomedical
  • On-chip Biotechnologies Co., Ltd.
  • Oxford Nanopore Technologies
  • Promega Corporation
  • QIAGEN N.V.
  • Rarecyte Inc
  • Sartorius AG
  • Takara Bio
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

第12章 附錄

簡介目錄
Product Code: BIOT2235

Global single cell analysis market is projected to be worth USD 10.57 billion by 2030

According to SPER Market Research, the single cell analysis market is estimated to reach USD 10.57 billion by 2030 with a CAGR of 14.6%. Single cell analysis is the study of transcriptomics, genomics and other cellular interactions at a single cell level. The rising prevalence of cancer creates urgent need for better diagnostic models which can be served by single cell analysis.

Impact of COVID-19 on the Single Cell Analysis Market

The COVID-19 pandemic has prompted the development and manufacturing of vaccines. The government initiatives to meet the vaccine demand has increased the adoption of single-cell analysis product. Single-cell analysis technique assist the researchers to understand immune response on single-cell basis in order to evaluate prognosis of disease, identify diagnostic markers and develop therapeutic interventions.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Product, By Technology, By Application, By End User
  • Geographies covered: North America, Europe, APAC, Latin America and the Middle East & Africa
  • Companies Covered: 10x Genomics, Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Corning Incorporated, Cytek Biosciences, Danaher Corporation, Fluidigm Corporation, Fluxion Biosciences, Illumina, Inc., Luminex Corporation, Menarini Silicon Biosystems, Inc., Merck KGAA, NanoCellect Biomedical, On-chip Biotechnologies Co., Ltd., Oxford Nanopore Technologies, Promega Corporation, QIAGEN N.V., Rarecyte Inc, Sartorius AG, Takara Bio, Tecan Group Ltd., Thermo Fisher Scientific, Inc.

Driver: Rising prevalence of Cancer

The prevalence of Cancer is increasing across the globe creating urgent need for extensive research and development for better diagnosis and therapeutic interventions. Single-cell analysis provides accurate diagnosis of cancer and enables early treatment. Single-cell analysis can be used in monitoring the progression of tumors.

Restraints: Budget constraints for expensive products

Single-cell analysis is an expensive technique as it requires to maintain quality standards and comply with the regulatory recommended guidelines. Additionally, maintenance and indirect costs also add up in total cost of ownership. Many academic laboratories can not afford such costly analytical instruments which restraints the growth of this market.

Opportunity: Growth potential in single cell sequencing

Single cell sequencing provides a powerful technology to identify biomarkers for the diagnosis of diseases and monitor the progression of disease as well as response of patient to the treatment. Due to the quality of analysis, there is a huge growth potential in this market. Thus, companies are focusing on advancement of more single cell sequencing instruments in the forecast period.

Single Cell Analysis Market by Product:

Based on product, market has been segmented into Consumables (Beads, Microplates, Reagents, Assay Kits [Immunoassays, Cell-based Assays], Other Consumables), Instruments (Flow Cytometers, NGS Systems, PCR Instruments, Spectrophotometers, Microscopes, Cell Counters, HCS Systems, Microarrays, Other Instruments, Single Cell Analysis, by Cell Type, Human Cells, Animal Cells, Microbial Cells)

Single Cell Analysis Market by Technique:

Based on technique, the market is segmented into Flow Cytometry, Next-generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, Other Techniques

Single Cell Analysis Market by Application:

Based on application, the market is segmented into Research Applications (Cancer, Immunology, Neurology, Stem Cell, Other Research Applications), Medical Applications (Noninvasive Prenatal Diagnosis, in Vitro Fertilization, Circulating Tumor Cell Detection)

Single Cell Analysis Market by End User:

Based on end user, the market is segmented into Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks & IVF Centers, Academic & research laboratories have the largest share of this market by end user owing to rising number of medical colleges and increasing funding for research in life science.

Single Cell Analysis Market by Region:

North America owns the largest share of this market due to factors such as rising funding for research & development, high adoption for new technology and presence of key players of this market in North America.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Single Cell Analysis Market
  • 4.4. Market Trends

5. Global Single Cell Analysis Market, By Product, 2019-2030 (USD Million)

  • 5.1. Consumables
    • 5.1.1. Beads
    • 5.1.2. Microplates
    • 5.1.3. Reagents
    • 5.1.4. Assay Kits
      • 5.1.4.1. Immunoassays
      • 5.1.4.2. Cell-based Assays
    • 5.1.5. Other Consumables (Culture Dishes, Flasks, Tubes, Cuvettes, Cryovials, Filtration Apparatus, Petri Dishes, Inserts, and Discs)
  • 5.2. Instruments
    • 5.2.1. Flow Cytometers
    • 5.2.2. NGS Systems
    • 5.2.3. PCR Instruments
    • 5.2.4. Spectrophotometers
    • 5.2.5. Microscopes
    • 5.2.6. Cell Counters
    • 5.2.7. HCS Systems
    • 5.2.8. Microarrays
    • 5.2.9. Other Instruments
    • 5.2.10. Single Cell Analysis, by Cell Type
    • 5.2.11. Human Cells
    • 5.2.12. Animal Cells
    • 5.2.13. Microbial Cells

6. Global Single Cell Analysis Market, By Technique, 2019-2030 (USD Million)

  • 6.1. Flow Cytometry
  • 6.2. Next-generation Sequencing
  • 6.3. Polymerase Chain Reaction
  • 6.4. Microscopy
  • 6.5. Mass Spectrometry
  • 6.6. Other Techniques

7. Global Single Cell Analysis Market, By Application, 2019-2030 (USD Million)

  • 7.1. Research Applications
    • 7.1.1. Cancer
    • 7.1.2. Immunology
    • 7.1.3. Neurology
    • 7.1.4. Stem Cell
    • 7.1.5. Other Research Applications
  • 7.2. Medical Applications
    • 7.2.1. Noninvasive Prenatal Diagnosis
    • 7.2.2. in Vitro Fertilization
    • 7.2.3. Circulating Tumor Cell Detection

8. Global Single Cell Analysis Market, By End User, 2019-2030 (USD Million)

  • 8.1. Academic & Research Laboratories
  • 8.2. Biotechnology & Pharmaceutical Companies
  • 8.3. Hospitals & Diagnostic Laboratories
  • 8.4. Cell Banks & IVF Centers

9. Global Single Cell Analysis Market, By Geography, 2019-2030 (USD Million)

  • 9.1. North America
    • 9.1.1. US
    • 9.1.2. Canada
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. UK
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of the World
    • 9.4.1. Latin America
    • 9.4.2. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Market Share Analysis, By Key Players
  • 10.3. Competitive Scenario
    • 10.3.1. Product Launches
    • 10.3.2. Partnerships, Collaborations and Agreements
    • 10.3.3. Acquisitions
    • 10.3.4. Expansions
    • 10.3.5. Other Developments

11. Company Profiles

  • 11.1. 10x Genomics
  • 11.2. Agilent Technologies, Inc.
  • 11.3. Apogee Flow Systems Ltd.
  • 11.4. Becton, Dickinson and Company
  • 11.5. BioMerieux SA
  • 11.6. Bio-Rad Laboratories
  • 11.7. Corning Incorporated
  • 11.8. Cytek Biosciences
  • 11.9. Danaher Corporation
  • 11.10. Fluidigm Corporation
  • 11.11. Fluxion Biosciences
  • 11.12. Illumina, Inc.
  • 11.13. Luminex Corporation
  • 11.14. Menarini Silicon Biosystems, Inc.
  • 11.15. Merck KGAA
  • 11.16. NanoCellect Biomedical
  • 11.17. On-chip Biotechnologies Co., Ltd.
  • 11.18. Oxford Nanopore Technologies
  • 11.19. Promega Corporation
  • 11.20. QIAGEN N.V.
  • 11.21. Rarecyte Inc
  • 11.22. Sartorius AG
  • 11.23. Takara Bio
  • 11.24. Tecan Group Ltd.
  • 11.25. Thermo Fisher Scientific, Inc.

12. Appendix